ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 136036 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 136036; 2) Community: the network communities that were significantly associated with the response to NSC 136036; 3) Molecule: the relationships between components within communities and NSC 136036; 4) MDR: the compounds that were significantly associated with the NSC 136036.

NSC Compound Enrichment Correlation
NSC 749146 Null 0.0303734648501639 0.12232555
NSC 750332 4-(4-chlorophenyl)-1-3-[(E)-3-(3,4,5-trimethoxyphenyl)-2-propenoyl]phenyl-2,3-dihydro-1H-2-imidazolone 0.0303734648501639 0.036011183
NSC 753222 3-Hydroxy-5,6-dihydro-6-imino-8,9-dimethylisoindolo-[2,1-a]quinoxaline 0.0303734648501639 0.14053319
NSC 756350 GW784752X 0.0303734648501639 -0.063515483
NSC 100071 component of Halotex 0.030556149892922 0.081000095
NSC 109451 Null 0.030556149892922 0.034498679
NSC 1393 4-APP 0.030556149892922 -0.10136004
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.030556149892922 -0.065625099
NSC 195327 4-APPT 0.030556149892922 0.24654634
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.030556149892922 -0.22303028
Total:55  Current:32    [First] [Prev] [Next] [Last]